|
1
|
DeSantis C, Ma J, Bryan L and Jemal A:
Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tzanninis IG, Kotteas EA,
Ntanasis-Stathopoulos I, Kontogianni P and Fotopoulos G: Management
and outcomes in metaplastic breast cancer. Clin Breast Cancer.
16:437–443. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sonnenblick A, Pondé N and Piccart M:
Metastatic breast cancer: The Odyssey of personalization. Mol
Oncol. 10:1147–1159. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hemmatzadeh M, Mohammadi H, Jadidi-Niaragh
F, Asghari F and Yousefi M: The role of oncomirs in the
pathogenesis and treatment of breast cancer. Biomed Pharmacother.
78:129–139. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Asghari F, Haghnavaz N, Baradaran B,
Hemmatzadeh M and Kazemi T: Tumor suppressor microRNAs: Targeted
molecules and signaling pathways in breast cancer. Biomed
Pharmacother. 81:305–317. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tavazoie SF, Alarcón C, Oskarsson T, Padua
D, Wang Q, Bos PD, Gerald WL and Massagué J: Endogenous human
microRNAs that suppress breast cancer metastasis. Nature.
451:147–152. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gravgaard KH, Lyng MB, Laenkholm AV,
Søkilde R, Nielsen BS, Litman T and Ditzel HJ: The miRNA-200 family
and miRNA-9 exhibit differential expression in primary versus
corresponding metastatic tissue in breast cancer. Breast Cancer Res
Treat. 134:207–217. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Korpal M, Lee ES, Hu G and Kang Y: The
miR-200 family inhibits epithelial-mesenchymal transition and
cancer cell migration by direct targeting of E-cadherin
transcriptional repressors ZEB1 and ZEB2. J Biol Chem.
283:14910–14914. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Elliman SJ, Howley BV, Mehta DS, Fearnhead
HO, Kemp DM and Barkley LR: Selective repression of the oncogene
cyclin D1 by the tumor suppressor miR-206 in cancers. Oncogenesis.
3:e1132014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Song G, Zhang Y and Wang L: MicroRNA-206
targets notch3, activates apoptosis, and inhibits tumor cell
migration and focus formation. J Biol Chem. 284:31921–31927. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kong XM, Zhang GH, Huo YK, Zhao XH, Cao
DW, Guo SF, Li AM and Zhang XR: MicroRNA-140-3p inhibits
proliferation, migration and invasion of lung cancer cells by
targeting ATP6AP2. Int J Clin Exp Pathol. 8:12845–12852.
2015.PubMed/NCBI
|
|
14
|
Zou MX, Huang W, Wang XB, Lv GH, Li J and
Deng YW: Identification of miR-140-3p as a marker associated with
poor prognosis in spinal chordoma. Int J Clin Exp Pathol.
7:4877–4885. 2014.PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hao L, Leng J, Xiao R, Kingsley T, Li X,
Tu Z, Yang X, Deng X, Xiong M, Xiong J and Zhang Q: Bioinformatics
analysis of the prognostic value of Tripartite Motif 28 in breast
cancer. Oncol Lett. 13:2670–2678. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wei C, Cheng J, Zhou B, Zhu L, Khan MA, He
T, Zhou S, He J, Lu X, Chen H, et al: Tripartite motif containing
28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1
protein. Sci Rep. 6:298222016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qi Z, Cai S, Cai J, Chen L, Yao Y, Chen L
and Mao Y: miR-491 regulates glioma cells proliferation by
targeting TRIM28 in vitro. BMC Neurol. 16:2482016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rodriguez A, Griffiths-Jones S, Ashurst JL
and Bradley A: Identification of mammalian microRNA host genes and
transcription units. Genome Res. 14:1902–1910. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fang Z, Yin S, Sun R, Zhang S, Fu M, Wu Y,
Zhang T, Khaliq J and Li Y: miR-140-5p suppresses the
proliferation, migration and invasion of gastric cancer by
regulating YES1. Mol Cancer. 16:1392017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lu Y, Qin T, Li J, Wang L, Zhang Q, Jiang
Z and Mao J: MicroRNA-140-5p inhibits invasion and angiogenesis
through targeting VEGF-A in breast cancer. Cancer Gene Ther.
24:386–392. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lan H, Chen W, He G and Yang S: miR-140-5p
inhibits ovarian cancer growth partially by repression of PDGFRA.
Biomed Pharmacother. 75:117–122. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hatakeyama S: TRIM proteins and cancer.
Nat Rev Cancer. 11:792–804. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen L, Chen DT, Kurtyka C, Rawal B, Fulp
WJ, Haura EB and Cress WD: Tripartite motif containing 28 (Trim28)
can regulate cell proliferation by bridging HDAC1/E2F interactions.
J Biol Chem. 287:40106–40118. 2012. View Article : Google Scholar : PubMed/NCBI
|
